sioy82

Biotech investor

[sioy82 @sioy82]

@martkyll Ei tuota keskimmäistä vaihtoehtoa ole ollut enää pääomatuloissa kahteen vuoteen. Se on joko minimi tai maksimi.

Samalla, kun tuo muutos tuli, niin muutettiin, ettei passiivisella omistuksella (tai vähäisellä kaupankäynnillä) saa lainkaan työhuonevähennystä.

[sioy82 @sioy82]

@Lord_of_Biotech $THRD BML Investment Partners 8,2 %

[sioy82 @sioy82]

@0x539dev @nordnetFI Tietoturvasta en tiedä, mutta huomasin viime kesän päivityksen jälkeen koodivirheitä. Ei mitään vakavaa kuitenkaan.

Ilmoitin asiasta ja vastaus oli; vien asian eteenpäin, mutta en lupaa, että korjataan. 😀

[sioy82 @sioy82]

@Varro_Analytics CRB-701 western study results next week. Abstract on Monday AH and presentation on Friday.

[sioy82 @sioy82]

@ArbitrageDaks Yesterday I received a small payment.

[Mark Minervini @markminervini]

You will never get huge returns with any real consistency holding a diversified portfolio of stocks through thick and thin. Big performance with little drawdown requires:
1. Timing
2. Turnover
3. Aggressive position sizing when trades are working
4. Cash or light positioning during bear markets
If you want to make great returns consistently, you must get off the idea of being right or wrong and instead learn how to lose much less when you're wrong than you make when you're right. I'm wrong just as much as I'm right. That's why I use stops.

[JTrader @jtraderco]

8 most famous risk management quotes to learn by heart

1. Paul Tudor Jones: The most important rule of trading is to play great defense, not great offense.

[Daily Stoic @dailystoic]

Stoic reminders from Marcus Aurelius:

1. Your task is to be good
2. If it’s humanly possible, you can do it
3. Most people are doing the best they can
4. The obstacle IS the way
5. Applause and fame are worthless
6. Life is short

[sioy82 @sioy82]

@JoseRestonVA @jfais20 Vk had great thesis.

[sioy82 @sioy82]

@lblegend33 Have people already forgotten this thread (GLYC's AML short thesis)? https://t.co/cByb6DIlys

[sioy82 @sioy82]

@RNAiAnalyst https://t.co/zoyrJ7s2PZ

[sioy82 @sioy82]

@RoccoLefkowitz2 After fail they have cash over $81. Net cash is about 54.

[sioy82 @sioy82]

@leveredvalue XOMA is paying between $2.3352 - $2.5879 cash plus CVR.

[sioy82 @sioy82]

@asayre07 For example Interactive Brokers paid my dividend last night.

[sioy82 @sioy82]

@JabroniCapital @JoeRetail2 If I may ask, was there an ADR fee? Thanks.

[sioy82 @sioy82]

@MassimoSTU @Lord_of_Biotech I think that buyout is going to be about $2,50 but it is really hard to tell how much they have spent last months. There were 28 workers (now still 12). Then you can give some value for CVR too. Personally I am not going to give it much.

[sioy82 @sioy82]

@MassimoSTU @Lord_of_Biotech Only if you are 100 % sure you would get $0,63.

[sioy82 @sioy82]

@trustfundgen @Lord_of_Biotech Seems like a longshot to me. Pivotal trial, accelerated approval or marketing application…

[sioy82 @sioy82]

@Stonkat_Ali I think we should hear next 30 days what is going to happen. For example exactly 30 days after KNTE did last RIF buyout was announced. At least I am hoping.

[sioy82 @sioy82]

@Stonkat_Ali Should be 5 / 55 left.